Evaluation of the Neurologic Assessment in Neuro-Oncology (NANO) criteria among brain cancer patients

Completed

• Conditions: glioma; 10029211; brain tumor

• Registration Number: NL-OMON56677
• Lead Sponsor: Dana-Farber/Harvard Cancer Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

suffering from a brain tumor
18 year or older
informed consent

Exclusion Criteria

not able to undergo a physical examination

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Interobserver variability of the criteria of each neurologic examination domain<br /><br>specified in the NANO scale</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>none</p><br>